ketoconazole has been researched along with Otomycosis in 2 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Otomycosis: Fungus infection of the external ear, usually by ASPERGILLUS species
Excerpt | Relevance | Reference |
---|---|---|
"Otomycosis is a common mycotic infection of the external auditory canal, and Aspergillus species are one of the most frequent causative agents worldwide." | 5.91 | In Vitro Combination of Terbinafine with Ketoconazole Against Aspergillus Species with Terbinafine High MIC Values Isolated From Otomycosis. ( Abastabar, M; Abbasi, K; Aghili, SR; Badali, H; Espahbodi, A; Faeli, L; Haghani, I; Hedayati, MT; Javidnia, J; Khojasteh, S; Moazeni, M; Nosratabadi, M; Roohi, B; Saeedi, M; Shokohi, T, 2023) |
"Two cases of otomycosis have been reported in patients undergoing tympanomastoidectomy." | 1.72 | Otomycosis caused by the cryptic and emerging species ( Alves, AI; Bezerra, JD; Buonafina-Paz, MD; Leal, MC; Leite-Andrade, MC; Lima-Neto, RG; Neves, RP; Pape, PL; Robert, E; Santos, FA, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Buonafina-Paz, MD | 3 |
Santos, FA | 3 |
Leite-Andrade, MC | 3 |
Alves, AI | 3 |
Bezerra, JD | 3 |
Leal, MC | 3 |
Robert, E | 3 |
Pape, PL | 3 |
Lima-Neto, RG | 3 |
Neves, RP | 3 |
Nosratabadi, M | 3 |
Espahbodi, A | 3 |
Hedayati, MT | 3 |
Shokohi, T | 3 |
Badali, H | 3 |
Saeedi, M | 3 |
Moazeni, M | 3 |
Aghili, SR | 3 |
Javidnia, J | 3 |
Faeli, L | 3 |
Khojasteh, S | 3 |
Roohi, B | 3 |
Abbasi, K | 3 |
Abastabar, M | 3 |
Haghani, I | 3 |
2 other studies available for ketoconazole and Otomycosis
Article | Year |
---|---|
Otomycosis caused by the cryptic and emerging species
Topics: Antifungal Agents; Aspergillus; Humans; Itraconazole; Ketoconazole; Otomycosis | 2022 |
Otomycosis caused by the cryptic and emerging species
Topics: Antifungal Agents; Aspergillus; Humans; Itraconazole; Ketoconazole; Otomycosis | 2022 |
Otomycosis caused by the cryptic and emerging species
Topics: Antifungal Agents; Aspergillus; Humans; Itraconazole; Ketoconazole; Otomycosis | 2022 |
Otomycosis caused by the cryptic and emerging species
Topics: Antifungal Agents; Aspergillus; Humans; Itraconazole; Ketoconazole; Otomycosis | 2022 |
Otomycosis caused by the cryptic and emerging species
Topics: Antifungal Agents; Aspergillus; Humans; Itraconazole; Ketoconazole; Otomycosis | 2022 |
Otomycosis caused by the cryptic and emerging species
Topics: Antifungal Agents; Aspergillus; Humans; Itraconazole; Ketoconazole; Otomycosis | 2022 |
Otomycosis caused by the cryptic and emerging species
Topics: Antifungal Agents; Aspergillus; Humans; Itraconazole; Ketoconazole; Otomycosis | 2022 |
Otomycosis caused by the cryptic and emerging species
Topics: Antifungal Agents; Aspergillus; Humans; Itraconazole; Ketoconazole; Otomycosis | 2022 |
Otomycosis caused by the cryptic and emerging species
Topics: Antifungal Agents; Aspergillus; Humans; Itraconazole; Ketoconazole; Otomycosis | 2022 |
In Vitro Combination of Terbinafine with Ketoconazole Against Aspergillus Species with Terbinafine High MIC Values Isolated From Otomycosis.
Topics: Antifungal Agents; Aspergillus; Humans; Ketoconazole; Microbial Sensitivity Tests; Otomycosis; Terbi | 2023 |
In Vitro Combination of Terbinafine with Ketoconazole Against Aspergillus Species with Terbinafine High MIC Values Isolated From Otomycosis.
Topics: Antifungal Agents; Aspergillus; Humans; Ketoconazole; Microbial Sensitivity Tests; Otomycosis; Terbi | 2023 |
In Vitro Combination of Terbinafine with Ketoconazole Against Aspergillus Species with Terbinafine High MIC Values Isolated From Otomycosis.
Topics: Antifungal Agents; Aspergillus; Humans; Ketoconazole; Microbial Sensitivity Tests; Otomycosis; Terbi | 2023 |
In Vitro Combination of Terbinafine with Ketoconazole Against Aspergillus Species with Terbinafine High MIC Values Isolated From Otomycosis.
Topics: Antifungal Agents; Aspergillus; Humans; Ketoconazole; Microbial Sensitivity Tests; Otomycosis; Terbi | 2023 |